Adeno-Associated Virus Gene Therapy Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adeno-Associated Virus (AAV) Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
1.2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adeno-Associated Virus (AAV) Gene Therapy Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Landscape
3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Company (2019-2024)
3.2 Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Adeno-Associated Virus (AAV) Gene Therapy Market Size Sites, Area Served, Product Type
3.4 Adeno-Associated Virus (AAV) Gene Therapy Market Competitive Situation and Trends
3.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Concentration Rate
3.4.2 Global 5 and 10 Largest Adeno-Associated Virus (AAV) Gene Therapy Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Adeno-Associated Virus (AAV) Gene Therapy Value Chain Analysis
4.1 Adeno-Associated Virus (AAV) Gene Therapy Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Adeno-Associated Virus (AAV) Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2019-2024)
6.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type (2019-2024)
7 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD) by Application (2019-2024)
7.3 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Application (2019-2024)
8 Adeno-Associated Virus (AAV) Gene Therapy Market Segmentation by Region
8.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region
8.2 North America
8.2.1 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Creative Biolabs
9.1.1 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Affinia Therapeutics
9.2.1 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.2.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.2.5 Affinia Therapeutics Business Overview
9.2.6 Affinia Therapeutics Recent Developments
9.3 Spark Therapeutics
9.3.1 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.3.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
9.3.5 Spark Therapeutics Business Overview
9.3.6 Spark Therapeutics Recent Developments
9.4 AGC Biologics
9.4.1 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.4.4 AGC Biologics Business Overview
9.4.5 AGC Biologics Recent Developments
9.5 StrideBio
9.5.1 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.5.4 StrideBio Business Overview
9.5.5 StrideBio Recent Developments
9.6 SIRION Biotech
9.6.1 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.6.4 SIRION Biotech Business Overview
9.6.5 SIRION Biotech Recent Developments
9.7 Neurophth Biotechnology
9.7.1 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.7.4 Neurophth Biotechnology Business Overview
9.7.5 Neurophth Biotechnology Recent Developments
9.8 Belief BioMed
9.8.1 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.8.4 Belief BioMed Business Overview
9.8.5 Belief BioMed Recent Developments
9.9 BiBo Biopharma Engineering Co., LTD.
9.9.1 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.9.4 BiBo Biopharma Engineering Co., LTD. Business Overview
9.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
9.10 Beihai Kangcheng
9.10.1 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.10.4 Beihai Kangcheng Business Overview
9.10.5 Beihai Kangcheng Recent Developments
9.11 PackGene Biotech
9.11.1 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.11.4 PackGene Biotech Business Overview
9.11.5 PackGene Biotech Recent Developments
9.12 Sarepta Therapeutics
9.12.1 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.12.4 Sarepta Therapeutics Business Overview
9.12.5 Sarepta Therapeutics Recent Developments
9.13 Carbon BioSciences
9.13.1 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.13.4 Carbon BioSciences Business Overview
9.13.5 Carbon BioSciences Recent Developments
9.14 Kelonia Therapeutics
9.14.1 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.14.4 Kelonia Therapeutics Business Overview
9.14.5 Kelonia Therapeutics Recent Developments
9.15 Roche
9.15.1 Roche Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.15.4 Roche Business Overview
9.15.5 Roche Recent Developments
9.16 Remedium Bio
9.16.1 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
9.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
9.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Market Performance
9.16.4 Remedium Bio Business Overview
9.16.5 Remedium Bio Recent Developments
10 Adeno-Associated Virus (AAV) Gene Therapy Regional Market Forecast
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast
10.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region
10.2.4 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adeno-Associated Virus (AAV) Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Type (2025-2030)
11.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adeno-Associated Virus (AAV) Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) by Company (2019-2024)
Table 6. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Gene Therapy as of 2022)
Table 8. Company Adeno-Associated Virus (AAV) Gene Therapy Market Size Sites and Area Served
Table 9. Company Adeno-Associated Virus (AAV) Gene Therapy Product Type
Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Adeno-Associated Virus (AAV) Gene Therapy
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Adeno-Associated Virus (AAV) Gene Therapy Market Challenges
Table 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (M USD)
Table 19. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Share by Type (2019-2024)
Table 21. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type (2019-2024)
Table 22. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
Table 23. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2019-2024) & (M USD)
Table 24. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2019-2024)
Table 25. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Application (2019-2024)
Table 26. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2019-2024) & (M USD)
Table 27. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2019-2024)
Table 28. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2019-2024) & (M USD)
Table 31. South America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2019-2024) & (M USD)
Table 33. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 34. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 35. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
Table 37. Creative Biolabs Business Overview
Table 38. Creative Biolabs Recent Developments
Table 39. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 40. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 41. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
Table 43. Affinia Therapeutics Business Overview
Table 44. Affinia Therapeutics Recent Developments
Table 45. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 46. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 47. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy SWOT Analysis
Table 49. Spark Therapeutics Business Overview
Table 50. Spark Therapeutics Recent Developments
Table 51. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 52. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 53. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 54. AGC Biologics Business Overview
Table 55. AGC Biologics Recent Developments
Table 56. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 57. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 58. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 59. StrideBio Business Overview
Table 60. StrideBio Recent Developments
Table 61. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 62. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 63. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 64. SIRION Biotech Business Overview
Table 65. SIRION Biotech Recent Developments
Table 66. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 67. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 68. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Neurophth Biotechnology Business Overview
Table 70. Neurophth Biotechnology Recent Developments
Table 71. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 72. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 73. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Belief BioMed Business Overview
Table 75. Belief BioMed Recent Developments
Table 76. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 77. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 78. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 79. BiBo Biopharma Engineering Co., LTD. Business Overview
Table 80. BiBo Biopharma Engineering Co., LTD. Recent Developments
Table 81. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 82. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 83. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Beihai Kangcheng Business Overview
Table 85. Beihai Kangcheng Recent Developments
Table 86. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 87. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 88. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 89. PackGene Biotech Business Overview
Table 90. PackGene Biotech Recent Developments
Table 91. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 92. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 93. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Sarepta Therapeutics Business Overview
Table 95. Sarepta Therapeutics Recent Developments
Table 96. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 97. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 98. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Carbon BioSciences Business Overview
Table 100. Carbon BioSciences Recent Developments
Table 101. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 102. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 103. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Kelonia Therapeutics Business Overview
Table 105. Kelonia Therapeutics Recent Developments
Table 106. Roche Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 107. Roche Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 108. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Roche Business Overview
Table 110. Roche Recent Developments
Table 111. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Basic Information
Table 112. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Overview
Table 113. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Remedium Bio Business Overview
Table 115. Remedium Bio Recent Developments
Table 116. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 117. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 119. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 120. South America Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 123. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Industrial Chain of Adeno-Associated Virus (AAV) Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (M USD)
Figure 10. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Share by Company in 2023
Figure 11. Adeno-Associated Virus (AAV) Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Adeno-Associated Virus (AAV) Gene Therapy Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Type
Figure 15. Market Size Share of Adeno-Associated Virus (AAV) Gene Therapy by Type (2019-2024)
Figure 16. Market Size Market Share of Adeno-Associated Virus (AAV) Gene Therapy by Type in 2022
Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application
Figure 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application (2019-2024)
Figure 21. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share by Application in 2022
Figure 22. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2019-2024)
Figure 24. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2023
Figure 26. U.S. Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2023
Figure 31. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2023
Figure 38. China Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (M USD)
Figure 44. South America Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2023
Figure 45. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 57. Global Adeno-Associated Virus (AAV) Gene Therapy Market Share Forecast by Application (2025-2030)
Industry Market Size
